Frequently Asked Questions
click on a question below to reveal the answer
What constitutes a "technical denial?"
Technical denials are issued when the provider does not submit clinical information or other documentation necessary to complete the review. A technical denial will also be issued when requested information is not submitted within the defined time frame.
What medical necessity criteria does Telligen use?
Criteria supports compliance with state and federal requirements, including California Department of Health Care Services (DHCS) Behavioral Health Information Notice (BHIN) 19-026, BHIN 22-017, as well as the Parity in Mental Health and SUD Services Final Rule (Title 42 CFR, part 438.910), which establish concurrent review standards for psychiatric inpatient hospital and psychiatric health facility services.
- Behavioral Health Information Notice (BHIN) 22-017 can be found here: BHIN 22-017
- Behavioral Health Information Notice (BHIN): BHIN 26-001
How do providers submit cases for review?
Service requests and medical records must be submitted to Telligen in the Qualitrac provider portal.
What part of the Concurrent Review process does Telligen cover?
Upon a hospital’s entry of a Medi-Cal beneficiary into Qualitrac, Telligen initiates the Concurrent Review process. We handle the full scope of requirements, including medical necessity criteria, TAR submissions, quality reviews, and appeals support.
Will Telligen conduct a concurrent review if a private insurance company is paying for the hospitalization?
Telligen performs Concurrent Reviews exclusively for beneficiaries who are either uninsured or covered by Medi-Cal within Participating Contracted Counties.
Am I required to submit a request if the patient is not eligible for Medi-Cal?
Not necessarily. Telligen is responsible for reviewing inpatient psychiatric admissions for Medi-Cal and Uninsured/Short-Doyle beneficiaries in participating counties. If the patient’s primary insurance is private, military, or Medicare, their admission does not require a Telligen review.
